Stigmine

A class of drugs that inhibit acetylcholinesterase

Stigmine refers to a class of cholinesterase inhibitors that are used in the treatment of various medical conditions, primarily those involving the neuromuscular junction. These compounds work by inhibiting the enzyme acetylcholinesterase, which breaks down the neurotransmitter acetylcholine. By preventing the breakdown of acetylcholine, stigmines increase its availability at synapses, thereby enhancing cholinergic transmission.

Mechanism of Action

Stigmines exert their effects by binding to the active site of acetylcholinesterase, thereby preventing the enzyme from hydrolyzing acetylcholine into choline and acetate. This inhibition leads to an accumulation of acetylcholine in the synaptic cleft, which enhances communication between nerves and muscles. The increased acetylcholine levels improve muscle contraction and are particularly beneficial in conditions where muscle weakness is a primary symptom.

Uses in Medicine

Stigmines are primarily used in the treatment of myasthenia gravis, a chronic autoimmune disorder characterized by muscle weakness. They are also employed in reversing the effects of non-depolarizing muscle relaxants after surgery and in the management of glaucoma and Alzheimer's disease.

Myasthenia Gravis

In myasthenia gravis, the immune system produces antibodies that block or destroy nicotinic acetylcholine receptors at the neuromuscular junction. Stigmines, such as pyridostigmine and neostigmine, help alleviate symptoms by increasing the concentration of acetylcholine, thus improving neuromuscular transmission.

Reversal of Neuromuscular Blockade

During surgical procedures, non-depolarizing muscle relaxants are often used to facilitate intubation and surgical access. Stigmines are administered postoperatively to reverse the effects of these muscle relaxants, allowing for the restoration of normal muscle function.

Glaucoma

In the treatment of glaucoma, stigmines reduce intraocular pressure by increasing the outflow of aqueous humor through the trabecular meshwork. This is achieved by enhancing the contraction of the ciliary muscle, which opens the trabecular meshwork and facilitates fluid drainage.

Alzheimer's Disease

Although not the primary treatment, stigmines can be used to manage symptoms of Alzheimer's disease by improving cholinergic function in the brain, which is often compromised in this condition.

Common Stigmines

Several stigmines are used in clinical practice, each with specific indications and pharmacokinetic properties:

• Pyridostigmine: Commonly used in the treatment of myasthenia gravis and as a reversal agent for neuromuscular blockade.

• Neostigmine: Used for similar indications as pyridostigmine, with a shorter duration of action.

• Physostigmine: Primarily used in the treatment of glaucoma and as an antidote for anticholinergic toxicity.

Chemical structure of pyridostigmine

Side Effects

The use of stigmines can lead to a range of side effects due to excessive cholinergic activity. Common side effects include:

• Bradycardia
• Hypotension
• Diarrhea
• Nausea
• Muscle cramps
• Increased salivation

In severe cases, excessive cholinergic stimulation can lead to a cholinergic crisis, characterized by muscle weakness, respiratory depression, and potentially life-threatening complications.

Related Pages

• Acetylcholinesterase
• Cholinergic crisis
• Neuromuscular junction
• Autoimmune disease